Medicalgorithmics S.A. Stock

Equities

MDG

PLMDCLG00015

Advanced Medical Equipment & Technology

Delayed Warsaw S.E. 05:13:48 2024-04-19 am EDT 5-day change 1st Jan Change
25.16 PLN +0.24% Intraday chart for Medicalgorithmics S.A. -3.31% -17.71%
Sales 2021 121M 29.63M Sales 2022 62.72M 15.42M Capitalization 122M 29.99M
Net income 2021 -181M -44.49M Net income 2022 -30M -7.37M EV / Sales 2021 0.92 x
Net Debt 2021 16.77M 4.12M Net cash position 2022 16.91M 4.16M EV / Sales 2022 1.68 x
P/E ratio 2021
-0.48 x
P/E ratio 2022
-2.3 x
Employees 122
Yield 2021 *
-
Yield 2022
-
Free-Float 50%
More Fundamentals * Assessed data
Dynamic Chart
Medicalgorithmics S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Medicalgorithmics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Medicalgorithmics S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Bio Fund Management Ltd. signed an agreement to acquire 100% stake in Kardiolytics Inc. for $44.9 million. CI
Medicalgorithmics S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Medicalgorithmics S.A. Secures FDA Approval for DeepRhytmAI Technology CI
Medicalgorithmics S.A. announced a financing transaction CI
Medicalgorithmics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Medicalgorithmics to Consider Finding Investor for Group, Sale of Significant Assets CI
Rafal Brzoska Withdrawn from Negotiations with Medicalgorithmics CI
Medicalgorithmics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Medicalgorithmics S.A. announced that it expects to receive PLN 15.58017 million in funding CI
Medicalgorithmics Starts Talks with Rafal Brzoska on Acquisition of Company's Shares CI
More news
1 day+0.16%
1 week-3.31%
Current month-5.67%
1 month-2.93%
3 months-14.49%
6 months-18.90%
Current year-17.71%
More quotes
1 week
24.88
Extreme 24.88
26.78
1 month
24.52
Extreme 24.52
27.90
Current year
24.52
Extreme 24.52
32.10
1 year
16.60
Extreme 16.6
46.80
3 years
5.50
Extreme 5.5
46.80
5 years
5.50
Extreme 5.5
46.80
10 years
5.50
Extreme 5.5
343.75
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 22-12-05
Members of the board TitleAgeSince
Director/Board Member 51 -
Director/Board Member - 22-11-15
Director/Board Member 40 22-06-30
More insiders
Date Price Change Volume
24-04-19 25.16 +0.24% 1 126
24-04-18 25.1 +0.24% 8,368
24-04-17 25.04 -1.49% 13,580
24-04-16 25.42 -1.85% 18,381
24-04-15 25.9 -0.38% 5,355

Delayed Quote Warsaw S.E., April 19, 2024 at 05:13 am EDT

More quotes
Medicalgorithmics SA is a Poland-based company engaged in the advanced medical equipment and technology industry. The Company develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.
More about the company